by S Gourlay 2024 Cited by 19Keywords - lisinopril, enalapril, ACE inhibitors, dosing with lOmg daily doses of lisinopril or compared to enalapril, following chronic administration.
separately for enalapril vs. ramipril, lisinopril vs. ramipril, and enalapril vs. lisinopril as dependent variables. Propensity scores were derived from all baseline variables except for ACEI dose equivalent, haemoglobin, and NT-proBNP using the multiple imputed baseline data sets.
by R Chou 2024 Cited by 4Benazepril, captopril, enalapril, and lisinopril are less dependent on Lisinopril vs. placebo. Mortality (6 weeks): 6.4% (619/9646) vs. 7.2%. (693
The relevant plot is shown in figure 7. The formal sensitivity analyses indicate only a small residual bias. The respective -values were 0.73, 0.64, and 0.80 for enalapril vs. ramipril, lisinopril vs. ramipril, and enalapril vs. lisinopril (no residual bias at =1.0).
by R Chou 2024 Cited by 4enalapril group at doses of 5 to 20 mg daily. As been due to dosing schedule. 1 fair-quality Lisinopril vs Enalapril: Class II: 58% vs 64
separately for enalapril vs. ramipril, lisinopril vs. ramipril, and enalapril vs. lisinopril as dependent variables. Propensity scores were derived from all baseline variables except for ACEI dose equivalent, haemoglobin, and NT-proBNP using the multiple imputed baseline data sets.
ACE: benazepril, lisinopril, enalapril, Continuation vs substitution vs interruption should be discussed with the prescribing transplant physician.
The ACEI agent was the dependent variable. 19 In a first step, propensity scores were calculated separately for enalapril vs. ramipril, lisinopril vs. ramipril, and enalapril vs. lisinopril as dependent variables. Propensity scores were derived from all baseline variables except for ACEI dose equivalent, haemoglobin, and N
The formal sensitivity analyses indicate only a small residual bias. The respective values were 0.73, 0.64, and 0.80 for enalapril vs. ramipril, lisinopril vs. ramipril, and enalapril vs. lisinopril (no residual bias at = 1.0). This means that in order to attribute a possible survival benefit to an unobserved covariate rather than the
Comments